NCT02303262 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02303262
Title	A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Sarcoma Alliance for Research through Collaboration
Indications	leiomyosarcoma
Therapies	Gemcitabine + Mocetinostat
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	City	State	Zip	Country	Details
Massachusetts General Hospital/Dana Farber Cancer Institute	Boston	Massachusetts	02114	United States	Details
Memorial Sloan Kettering Cancer Center	New York	New York	10065	United States	Details
Ohio State University	Columbus	Ohio	43210	United States	Details
University of Michigan	Ann Arbor	Michigan	48109	United States	Details
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02303262Clinical Trial Detail